{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BP3B", "Colon cancer", "Medicinal plant", "Patient-derived tumor xenograft"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27863496", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "16"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "11", "Day": "18"}], "ELocationID": ["473"], "Language": ["eng"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "16", "Issue": "1", "PubDate": {"Year": "2016", "Month": "Nov", "Day": "18"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model.", "Pagination": {"StartPage": "473", "MedlinePgn": "473"}, "Abstract": {"AbstractText": ["KIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts. Our preliminary study identified that BP3B exhibited potent anti-proliferative activity against various types of cancer cell lines in vitro. Because the in vivo anti-tumor effect of BP3B is not evaluated before clinical trial, we want to test it using patient's samples.", "To confirm the in vivo anti-cancer effect of BP3B, we used genetically characterized patient-derived colon tumor xenograft (PDTX) mouse model. Anti-cancer activity was evaluated with apoptosis, proliferation, angiogenesis and histological analysis.", "Oral administration of BP3B significantly inhibited the tumor growth in two PDTX models. Furthermore, TUNEL assay showed that BP3B induced apoptosis of tumor tissues, which was associated with degradation of PARP and Caspase 8 and activation of Caspase 3. We also observed that BP3B inhibited cancer cell proliferation by down-regulation of Cyclin D1 and induction of p27 proteins. Inhibition of angiogenesis in BP3B-treated group was observed with immunofluorescence staining using CD31 and Tie-2 antibodies.", "These findings indicated that BP3B has a strong growth-inhibitory activity against colon cancer in in vivo model and will be a good therapeutic candidate for treatment of refractory colon cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, 155 Gaetbel-ro Yeonsu-gu, Incheon, 21999, Republic of Korea."}], "LastName": "Kim", "ForeName": "Hye-Youn", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea."}], "LastName": "Kim", "ForeName": "Jinhee", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, 155 Gaetbel-ro Yeonsu-gu, Incheon, 21999, Republic of Korea."}], "LastName": "Ha Thi", "ForeName": "Huyen Trang", "Initials": "HT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea."}], "LastName": "Bang", "ForeName": "Ok-Sun", "Initials": "OS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Sugery, Gil Medical Center, Gachon University, Incheon, 21565, Republic of Korea."}], "LastName": "Lee", "ForeName": "Won-Suk", "Initials": "WS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, 155 Gaetbel-ro Yeonsu-gu, Incheon, 21999, Republic of Korea. sthong@gachon.ac.kr."}], "LastName": "Hong", "ForeName": "Suntaek", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Colonic Neoplasms"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer. 2009;9:489\u201399. doi: 10.1038/nrc2645.", "ArticleIdList": ["10.1038/nrc2645", "19536109"]}, {"Citation": "Buyse M, Thirion P, Carlson R, Burzykowski T, Molenberghs G, Piedbois P. Tumour response to first line chemotherapy improves the survival of patients with advanced colorectal cancer. Lancet. 2000;356:373\u20138. doi: 10.1016/S0140-6736(00)02528-9.", "ArticleIdList": ["10.1016/S0140-6736(00)02528-9", "10972369"]}, {"Citation": "Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343:905\u201314. doi: 10.1056/NEJM200009283431302.", "ArticleIdList": ["10.1056/NEJM200009283431302", "11006366"]}, {"Citation": "Douillard J, Cunningham D, Roth A, Navarro M, James R, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000;355:1041\u20137. doi: 10.1016/S0140-6736(00)02034-1.", "ArticleIdList": ["10.1016/S0140-6736(00)02034-1", "10744089"]}, {"Citation": "Knight R, Miller L, Pirotta N, Elfring G, Locker P, Saltz L. First-line irinotecan (C), fluorouracil (F), leucovorin (L) especially improves survival (OS) in metastatic colorectal cancer (MCRC) patients (PT) with favorable prognostic indicators. Proc Am Soc Clin Oncol. 2000;19:991a."}, {"Citation": "de Gramont AD, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938\u201347.", "ArticleIdList": ["10944126"]}, {"Citation": "Young A, Rea D. ABC of colorectal cancer: treatment of advanced disease. BMJ. 2000;321:1278\u201381. doi: 10.1136/bmj.321.7271.1278.", "ArticleIdList": ["10.1136/bmj.321.7271.1278", "PMC1119016", "11082094"]}, {"Citation": "Iacovelli R, Pietrantonio F, Maggi C, de Braud F, Di Bartolomeo M. Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials. Crit Rev Oncol Hematol. 2015;S1040:30043.", "ArticleIdList": ["26481953"]}, {"Citation": "Saito RF, Tortelli TC, Jacomassi MD, Otake AH, Chammas R. Emerging targets for combination therapy in melanomas. FEBS Lett. 2015;589:3438\u201348. doi: 10.1016/j.febslet.2015.09.022.", "ArticleIdList": ["10.1016/j.febslet.2015.09.022", "26450371"]}, {"Citation": "Hazama S, Nakamura Y, Tanaka H, Hirakawa K, Tahara K, Shimizu R, Ozasa H, Etoh R, Sugiura F, Okuno K, Furuya T, Nishimura T, Sakata K, Yoshimatsu K, Takenouchi H, Tsunedomi R, Inoue Y, Kanekiyo S, Shindo Y, Suzuki N, Yoshino S, Shinozaki H, Kamiya A, Furukawa H, Yamanaka T, Fujita T, Kawakami Y, Oka M. A phase IotaI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study) J Transl Med. 2014;12:108. doi: 10.1186/1479-5876-12-108.", "ArticleIdList": ["10.1186/1479-5876-12-108", "PMC4021539", "24884643"]}, {"Citation": "Dorff TB, Groshen S, Tsao-Wei DD, Xiong S, Gross ME, Vogelzang N, Quinn DI, Pinski JK. A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2014;17:359\u201365. doi: 10.1038/pcan.2014.37.", "ArticleIdList": ["10.1038/pcan.2014.37", "PMC4234307", "25245366"]}, {"Citation": "Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen EA, Liu SH, Cheng YC. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med. 2010;2:45ra59. doi: 10.1126/scitranslmed.3001270.", "ArticleIdList": ["10.1126/scitranslmed.3001270", "20720216"]}, {"Citation": "Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer Res. 2006;66:3351\u20134. doi: 10.1158/0008-5472.CAN-05-3627.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-3627", "16585151"]}, {"Citation": "Boedigheimer MJ, Freeman DJ, Kiaei P, Damore MA, Radinsky R. Gene expression profiles can predict panitumumab monotherapy responsiveness in human tumor xenograft models. Neoplasia. 2013;15:125\u201332. doi: 10.1593/neo.121038.", "ArticleIdList": ["10.1593/neo.121038", "PMC3579315", "23441127"]}, {"Citation": "Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M, Peacock CD, Watkins DN. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 2009;69:3364\u201373. doi: 10.1158/0008-5472.CAN-08-4210.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-4210", "PMC2821899", "19351829"]}, {"Citation": "Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De Pinieux G, Judde JG, Rebucci M, Tran-Perennou C, Sastre-Garau X, Sigal-Zafrani B, Delattre O, Dieras V, Poupon MF. A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin Cancer Res. 2009;13:3989\u201398. doi: 10.1158/1078-0432.CCR-07-0078.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-0078", "17606733"]}, {"Citation": "Fiebig HH, Maier A, Burger AM. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Euro J Cancer. 2004;40:802\u201320. doi: 10.1016/j.ejca.2004.01.009.", "ArticleIdList": ["10.1016/j.ejca.2004.01.009", "15120036"]}, {"Citation": "Jin K, Teng L, Shen Y, He K, Xu Z, Li G. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clin Transl Oncol. 2010;12:473\u201380. doi: 10.1007/s12094-010-0540-6.", "ArticleIdList": ["10.1007/s12094-010-0540-6", "20615824"]}, {"Citation": "Lee YJ, Kim NS, Kim H, Yi JM, Oh SM, Bang OS, Lee J. Cytotoxic and anti-inflammatory constituents from the seeds of Descurainia sophia. Arch Pharm Res. 2013;36:536\u201341. doi: 10.1007/s12272-013-0066-x.", "ArticleIdList": ["10.1007/s12272-013-0066-x", "23435946"]}, {"Citation": "Khan M, Xiao Y, Yu B, Wang N, Rasul A, Yi F, Yang L, Yang H, Ma T. Artabotryside A, a constituent from Descurainia sophia (L.) induces cell death in U87 glioma cells through apoptosis and cell cycle arrest at G2/M phase. J Med Plants Res. 2012;6:3754\u201365."}, {"Citation": "Sun K, Li X, Li W, Wang J, Liu J, Sha Y. Two new lactones and one new aryl-8-oxa-bicyclo[3,2,1]oct-3-en-2-one from Descurainia sophia. Chem Pharm Bull. 2004;52:1483\u20136. doi: 10.1248/cpb.52.1483.", "ArticleIdList": ["10.1248/cpb.52.1483", "15577251"]}, {"Citation": "Lee J, Lee YJ, Kim J, Bang OS. Pyranocoumarins from root extracts of Peucedanum praeruptorum Dunn with multidrug resistance reversal and anti-inflammatory activities. Molecules. 2015;20:20967\u201378. doi: 10.3390/molecules201219738.", "ArticleIdList": ["10.3390/molecules201219738", "PMC6332054", "26610461"]}, {"Citation": "Uto T, Tung NH, Appiah-Opong R, Aning A, Morinaga O, Edoh D, Nyarko K, Shoyama Y. Antiproliferative and pro-apoptotic activity of diarylheptanoids isolated from the bark of alnus japonica in human leukemia cell lines. Am J Chin Med. 2015;43:757\u201367. doi: 10.1142/S0192415X15500470.", "ArticleIdList": ["10.1142/S0192415X15500470", "26119959"]}, {"Citation": "Kang S, Kim JE, Li Y, Jung SK, Song NR, Thimmegowda NR, Kim BY, Lee HJ, Bode AM, Dong Z, Lee KW. Hirsutenone in Alnus extract inhibits akt activity and suppresses prostate cancer cell proliferation. Mol Carcinog. 2015;54:1354\u201362. doi: 10.1002/mc.22211.", "ArticleIdList": ["10.1002/mc.22211", "25213146"]}, {"Citation": "Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 1992;340:1120\u20134. doi: 10.1016/0140-6736(92)93150-L.", "ArticleIdList": ["10.1016/0140-6736(92)93150-L", "1279332"]}, {"Citation": "Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. International journal of cancer. Int J Cancer. 1993;55:371\u20134. doi: 10.1002/ijc.2910550305.", "ArticleIdList": ["10.1002/ijc.2910550305", "7690738"]}, {"Citation": "Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Nat Cancer Inst. 1992;84:1875\u201387. doi: 10.1093/jnci/84.24.1875.", "ArticleIdList": ["10.1093/jnci/84.24.1875", "1281237"]}, {"Citation": "Khodarahmi E, Asghari GH, Hassanzadeh F, Mirian M, Khodarahmi GA. Cytotoxic evaluation of volatile oil from Descurainia sophia seeds on MCF-7 and HeLa cell lines. Res Pharm Sci. 2015;10:169\u201376.", "ArticleIdList": ["PMC4584456", "26487894"]}, {"Citation": "Yu PJ, Jin H, Zhang JY, Wang GF, Li JR, Zhu ZG, Tian YX, Wu SY, Xu W, Zhang JJ, Wu SG. Pyranocoumarins isolated from Peucedanum praeruptorum Dunn suppress lipopolysaccharide-induced inflammatory response in murine macrophages through inhibition of NF-kappaB and STAT3 activation. Inflammation. 2012;35:967\u201377. doi: 10.1007/s10753-011-9400-y.", "ArticleIdList": ["10.1007/s10753-011-9400-y", "22083490"]}, {"Citation": "Liang T, Yue W, Li Q. Chemopreventive effects of Peucedanum praeruptorum DUNN and its major constituents on SGC7901 gastric cancer cells. Molecules. 2010;15:8060\u201371. doi: 10.3390/molecules15118060.", "ArticleIdList": ["10.3390/molecules15118060", "PMC6259126", "21063269"]}, {"Citation": "Yang L, Li XB, Yang Q, Zhang K, Zhang N, Guo YY, Feng B, Zhao MG, Wu YM. The neuroprotective effect of praeruptorin C against NMDA-induced apoptosis through down-regulating of GluN2B-containing NMDA receptors. Toxicol In Vitro. 2013;27:908\u201314. doi: 10.1016/j.tiv.2013.01.001.", "ArticleIdList": ["10.1016/j.tiv.2013.01.001", "23313464"]}, {"Citation": "Sung SH, Lee M. Anti-adipogenic activity of a new cyclic diarylheptanoid isolated from Alnus japonica on 3\u00a0T3-L1 cells via modulation of PPARgamma, C/EBPalpha and SREBP1c signaling. Bioorg Med Chem Lett. 2015;25:4648\u201351. doi: 10.1016/j.bmcl.2015.08.032.", "ArticleIdList": ["10.1016/j.bmcl.2015.08.032", "26341132"]}, {"Citation": "Tung NH, Suzuki M, Uto T, Morinaga O, Kwofie KD, Ammah N, Koram KA, Aboagye F, Edoh D, Yamashita T, Yamaguchi Y, Setsu T, Yamaoka S, Ohta N, Shoyama Y. Anti-trypanosomal activity of diarylheptanoids isolated from the bark of Alnus japonica. Am J Chin Med. 2014;42:1245\u201360. doi: 10.1142/S0192415X14500785.", "ArticleIdList": ["10.1142/S0192415X14500785", "25178281"]}, {"Citation": "Gura T. Systems for identifying new drugs are often faulty. Science. 1997;278:1041\u20132. doi: 10.1126/science.278.5340.1041.", "ArticleIdList": ["10.1126/science.278.5340.1041", "9381203"]}, {"Citation": "Zhao X, Liu Z, Yu L, Zhang Y, Baxter P, Voicu H, Gurusiddappa S, Luan J, Su JM, Leung HC, Li XN. Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma. Neuro Oncol. 2012;14:574\u201383. doi: 10.1093/neuonc/nos061.", "ArticleIdList": ["10.1093/neuonc/nos061", "PMC3337308", "22459127"]}, {"Citation": "Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E. Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Res. 2012;14:R11. doi: 10.1186/bcr3095.", "ArticleIdList": ["10.1186/bcr3095", "PMC3496128", "22247967"]}, {"Citation": "Gutmann DH, Maher EA, Van Dyke T. Mouse models of human cancers consortium workshop on nervous system tumors. Cancer Res. 2006;66:10\u20133. doi: 10.1158/0008-5472.CAN-05-3180.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-3180", "16397207"]}, {"Citation": "Lee WS, Kim HY, Seok JY, Jang HH, Park YH, Kim SY, Shin DB, Hong S. Genomic profiling of patient-derived colon cancer xenograft models. Medicine. 2014;93:e298. doi: 10.1097/MD.0000000000000298.", "ArticleIdList": ["10.1097/MD.0000000000000298", "PMC4603094", "25526474"]}, {"Citation": "Martinez-Garcia R, Juan D, Rausell A, Munoz M, Banos N, Menendez C, Lopez-Casas PP, Rico D, Valencia A, Hidalgo M. Transcriptional dissection of pancreatic tumors engrafted in mice. Genome Med. 2014;6:27. doi: 10.1186/gm544.", "ArticleIdList": ["10.1186/gm544", "PMC4062047", "24739241"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "5", "Day": "23"}, {"Year": "2016", "Month": "11", "Day": "3"}, {"Year": "2016", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["27863496", "PMC5116142", "10.1186/s12906-016-1447-8", "10.1186/s12906-016-1447-8"]}}], "PubmedBookArticle": []}